.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Dow
Express Scripts
Colorcon
Chinese Patent Office
Harvard Business School
Johnson and Johnson
US Department of Justice
Mallinckrodt
Deloitte

Generated: June 26, 2017

DrugPatentWatch Database Preview

SODIUM NITROPRUSSIDE Drug Profile

« Back to Dashboard

Which patents cover Sodium Nitroprusside, and when can generic versions of Sodium Nitroprusside launch?

Sodium Nitroprusside is a drug marketed by Namigen Llc, Abraxis Pharm, Akorn, Teva Parenteral, Baxter Hlthcare, and Nexus Pharms. and is included in six NDAs.

The generic ingredient in SODIUM NITROPRUSSIDE is sodium nitroprusside. There are one thousand three hundred and seventy-nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.

Summary for Tradename: SODIUM NITROPRUSSIDE

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list3
Clinical Trials: see list2,361
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SODIUM NITROPRUSSIDE at DailyMed

Pharmacology for Tradename: SODIUM NITROPRUSSIDE

Drug ClassVasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Namigen Llc
SODIUM NITROPRUSSIDE
sodium nitroprusside
INJECTABLE;INJECTION207426-001Dec 8, 2016APRXNoNo► Subscribe► Subscribe
Teva Parenteral
SODIUM NITROPRUSSIDE
sodium nitroprusside
INJECTABLE;INJECTION073465-001Mar 30, 1992DISCNNoNo► Subscribe► Subscribe
Abraxis Pharm
SODIUM NITROPRUSSIDE
sodium nitroprusside
INJECTABLE;INJECTION070031-001Jan 17, 1985DISCNNoNo► Subscribe► Subscribe
Akorn
SODIUM NITROPRUSSIDE
sodium nitroprusside
INJECTABLE;INJECTION208635-001May 4, 2017APRXNoNo► Subscribe► Subscribe
Nexus Pharms
SODIUM NITROPRUSSIDE
sodium nitroprusside
INJECTABLE;INJECTION207499-001May 25, 2017APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Deloitte
Chinese Patent Office
Johnson and Johnson
AstraZeneca
Baxter
Harvard Business School
Federal Trade Commission
Dow
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot